edrugsearch.com
Is Januvia worth the price?
The Type 2 diabetes drug Januvia (sitagliptin) has become a source of controversy after the drug's maker, Merck, funded a letter to doctors by CVS Caremark, the pharmacy benefits manager, urging the physicians to add the drug to specific patients' treatment regimens. Januvia costs as much